Results
Filtros
Anvisa swears in new directors in ceremony this Wednesday (10), follow it here
Live broadcast will be held on the Agency's YouTube channel; board will have a strategic role in topics such as cannabis regulation in Brazil
Anvisa has new approved directors
Confirmed appointments include Leandro Safatle, Thiago Campos, and Daniela Cerqueira
Anvisa Regulatory Agenda 2026 - 2027 opens space for society suggestions, including on cannabis
Population and regulated sectors have the opportunity to indicate topics of interest for the next biennium
Proposal to regulate cannabis cultivation is taken off Anvisa's meeting agenda
Decision postpones vote on new rules for cultivating low-THC varieties; new date for analysis not yet defined
Request for cannabis-based medicine without registration at Anvisa must be judged by the Federal Justice
STJ decision reinforces federal competence for actions involving unregistered drugs at the regulatory agency
Request for cannabis-based medicine without registration at Anvisa must be judged by the Federal Court
STJ decision reinforces federal jurisdiction for actions involving unregistered drugs at the regulatory agency
Anvisa Nominees' Hearing Scheduled in Senate
Social Affairs Committee to analyze four names for leadership positions in health agencies
Anvisa may vote on rules for national cultivation and control of cannabis this Wednesday (13)
Change may authorize cultivation by companies under strict control, with a limit of 0.3% THC; measure complies with a decision from the Superior Court of Justice (STJ) related to cultivation regulation.
New Anvisa directors move forward for Senate confirmation hearing
Social Affairs Committee confirms Safatle, Cerqueira, and Cardoso's names, in a moment of important reforms at the agency
UFLA integrates group presenting document to Anvisa on cannabis in scientific research and therapeutic use
Letter brings together experts from across the country and includes UFLA participation
Univali authorized by Anvisa to perform analyses of Cannabis products
New authorization expands university's scope in Reblas and reinforces quality control of plant derivatives in the national market
Ministry of Health and ANVISA receive Technical Note identifying 481 barriers to scientific development of cannabis in Brazil
Document developed by a group with 31 Brazilian academic and research institutions points out regulatory barriers and suggests an agile framework to strengthen the scientific and technological sector
Market expansion drives opening of Anvisa-regulated cannabis pharmacy in Paraná
Curitiba welcomes its first exclusive medicinal cannabis pharmacy, in a market that grew from R$ 38.5 million in 2022 to R$ 237.8 million in 2025, while Paraná accounts for only 2.4% of sales, indicating great potential in the state with 11 million inhabitants
“Special Moment for the Industry”: Executive Foresees Advancements with Anvisa's Review
Gustavo Palhares believes that regulatory review could streamline prescription, expand access, and raise technical requirements in the medical cannabis sector
Cannabidiol grows over 70% in the pharmacy channel; Anvisa's RDC 327 review generates optimism in the sector
According to Filipe Campos, from Close-Up International, the market could expand even further with rule updates and greater medical adherence
Lula appoints new directors for regulatory agencies, including Anvisa
The President emphasized the responsibility of the appointees and reinforced the importance of the agencies for the country's development
FNE promises to expedite cannabis exports to Brazil; agency seeks to understand Anvisa rules
Director-General of the National Narcotics Fund of Colombia, Milver Rojas, states that the process will be immediate once Anvisa confirms and foresees a return to the four to five-day deadline for each authorization
Cannabis Parliamentary Front launches R$ 1.25 million tender and demands changes in Anvisa at hearing in Alesp
Public hearing will present a balance of the first year of cannabis in the São Paulo public health system and will encourage projects in science, innovation, and social impact
CRF-SP warns of risk of setback and legal uncertainty in the review of the Cannabis regulation
According to Marcelo Polacow Bisson, excluding pharmacies' manipulation leads to lack of assistance; Anvisa's proposed text on the Cannabis regulation is also criticized for bypassing procedural rites
Cannabis importation in SP grows 6.2% in the 1st semester of 2025
Anvisa authorizations for importing cannabidiol in São Paulo increased by 6.2% between January and July 2025, consolidating the state as a leader in requests and reflecting the expanded access through the SUS